AI, Accessibility, and At-Home Care Drive Investment | StartUp Health Insights: Week of Jul 23, 2024

This week's health innovation funding highlights advancements in AI-powered solutions, improving patient access to care, expanding at-home healthcare options, enhancing patient engagement and privacy, and more.

This week’s reported health innovation funding included:

CytoReason, a Tel Aviv, Israel-based developer of computational disease models for predictive insights, raised $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific. <source>

Truvian Health, a San Diego, CA-based provider of a blood testing platform, raised $74M led by Wittington Ventures and Great Point Ventures, with participation from DNS Capital, Medical Excellence Capital, Tao Capital, TYH Capital, and 7wireVentures. <source>

Brenig Therapeutics, a Dover, DE-based neurology-focused drug development company utilizing an AI/ML-based discovery platform, raised $65M led by NEA, with participation from OrbiMed, Torrey Pines Investments. and BioGeneration Ventures. <source>

Loyal, an Atlanta, GA-based healthcare technology company focused on digital patient engagement, raised $33.5M from Concord Health Partners and multiple strategic investors. <source>

Freshpaint, a San Francisco, CA-based provider of a healthcare privacy platform, raised $30M led by Threshold, with participation from SignalFire, Intel Capital, Y Combinator, and Zero Prime. <source>

Q Bio, a San Carlos, CA-based startup developing their own full-body scanner, raised $27M from Khosla Ventures, Andreessen Horowitz, Founders Fund, and TELUS. <source>

Thoughtful AI, an Austin, TX-based developer of AI-powered revenue cycle automation, raised $20M led by Drive Capital, with participation from TriplePoint Capital. <source>

Vitable Health, a Philadelphia, PA-based startup that aims to make healthcare more affordable for hourly employees at small businesses, raised a $16M led by Cherryrock Capital, with participation from Newark Venture Partners, Citi Impact Fund, First Round Capital, Commerce Ventures, and Y Combinator. <source>

After.com, a Provo, UT-based online platform that helps families navigate end-of-life services, raised $10M led by HIPstr. <source>

Eden, a Mexico City, Mexico-based startup that uses LLMs to help radiologists process vast amounts of medical data, raised $10M led by Sierra Ventures, with participation from Kaszek, Alt Capital, Y Combinator, and Khosla Ventures. <source>

Juno, a San Diego, CA-based company that provides child disability insurance, raised $8.5M led by Spero Ventures, with participation from Floating Point, Newark Ventures, and WVV Capital. <source>

Kins, a Boston, MA-based digital-first hybrid care physical therapy practice, raised $7M from Healthworx, Redesign Health, W Health Ventures, and Asahi Kasei Ventures. <source>

Endless Health, an Austin, TX-based end-to-end at-home testing and preventive medicine company, raised $4.5M led by Next Coast Ventures and Asset Management Ventures, with participation from Antler Elevate. <source>

Briefly Bio, a London, UK-based biotech startup that has developed AI software that makes lab work more reproducible, raised $1.2M led by Compound VC, with participation from NP Hard, Tiny VC, and angel investors. <source>

Trait, a Berlin, Germany-based provider of a fitness training app, raised €1M ($1.1M) from HTGF, better ventures, and others. <source>

REMSpace, a San Francisco, CA-based neurotechnology company specializing in lucid dreaming studies, raised $1M from undisclosed investors. <source>


Data is from StartUp Health Insights, the most comprehensive funding database for health innovation.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.


Call for Alzheimer’s Innovation

With support from the Alzheimer’s Drug Discovery Foundation (ADDF) and Gates Ventures, we’ve launched a new global initiative created to develop a collaborative innovation community alongside leading companies, research teams, and stakeholders with a mission to accelerate progress in prevention, diagnosis, and management of Alzheimer’s disease and related dementias. Learn more and apply for an Alzheimer’s Moonshot Fellowship.

Become a Health Moonshot Champion

Health moonshots are fueled by passionate families, foundations, and industry organizations committed to achieving health moonshots. Learn how you can join other champions of the T1D Moonshot or one of our other global health moonshots.


Follow us on social media for daily updates on Health Transformers: X (Twitter), LinkedIn, Facebook, and Instagram.

Previous
Previous

TELL Is Building the Leading Voice Biomarkers for Latin America

Next
Next

RetiSpec’s AI-Driven Eye Test Detects Alzheimer’s Early